CRSP
WATCH CRISPR Therapeutics AG · US
—
—
Prices as of close 2026-07-28
Strong gene-editing platform, liquid shares, and durable investor interest support upside from clinical catalysts.
Buy signals
- ▸Morningstar flags it as one of the most undervalued biotech stocks.
Related Biotech picks
AI-generated research for educational purposes only — not investment advice. Prices are end-of-day.